Independent Director · National Health Investors Inc. (NHI)

Chair, Compensation Committee

James R. Jobe director compensation at National (FY2025): $226K

Fiscal year 2025 director compensation for James R. Jobe at National Health Investors Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 3, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get James R. Jobe’s full pay file as a PDF — free

More than this page: up to 10 years of James’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track James R. Jobe and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

National Health Investors Director Compensation Table · all 3 fiscal years held
In US dollars, as National Health Investors reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$137,500$0$88,380$0$225,880
FY2024$125,000$0$70,792$0$195,792
FY2023$110,000$0$70,860$0$180,860

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: National Health Investors Inc. DEF 14A filed April 3, 2026, accession 0000877860-26-000098, and prior-year filings. Open the filing on EDGAR.

How this page was built: the National Health Investors Inc. filed document, accession 0000877860-26-000098. Every figure is read from that document and cited to the page and table it appears in. Filed April 3, 2026.

Get the National Health Investors Board Governance Report

$225,880 James R. Jobe, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 3, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

National Health Investors pays directors a $75,000 cash retainer and $88,380 in equity.

Committees

FY2025 · as the proxy prints them

Audit · Compensation (Chair)

The rest of the National Health Investors board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Candice W. ToddIndependent Director$240,880
D. Eric MendelsohnDirector—
Lilly H. DonohueIndependent Director—
Robert A. McCabe, JrChair of the Board$290,880
Robert G. AdamsIndependent Director$205,880
Robert W. Chapin, JrIndependent Director$176,360
Tracy M.J. ColdenIndependent Director$225,880

The full National Health Investors compensation record

free company brief

This page is one director within National Health Investors's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the National Health Investors proxy · each links to its own free brief

Order NHI

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report